Beyond Regulatory and HTA Success: Reaching Physicians and Patients

Statisticians play a significant role in the clinical development of pharmaceutical products and medical devices. Their primary focus is to design and analyze clinical trials to provide evidence for regulatory approval and Health Technology Assessment (HTA). However, despite their valuable contributions, statisticians rarely get the chance to communicate directly with physicians, caregivers, and patients, the last hurdle in the medical affairs of pharmaceutical products. Communication often relies on multiple layers such as publications, slide sets, promotional material, and sales representatives. Poor communication of data can lead to misunderstandings, harm patients and even lead to legal issues. This is where statisticians can have a big impact.

In this episode, we discuss how statisticians can enhance their capabilities to reach physicians and patients beyond regulatory and HTA success. We also talk about the following points: